Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy in elderly people.

L J Stephen1, M J Brodie

  • 1University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK.

Lancet (London, England)
|May 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perampanel for focal epilepsy: insights from early clinical experience.

Acta neurologica Scandinavica·2015
Same author

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Acta neurologica Scandinavica. Supplementum·2012
Same author

Patterns of treatment response in newly diagnosed epilepsy.

Neurology·2012
Same author

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Acta neurologica Scandinavica·2011
Same author

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Biochemical pharmacology·2010
Same author

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Neurology·2010
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Epilepsy is most common in older adults, often linked with other diseases. Effective antiepileptic drug treatment can control seizures in 70% of elderly patients, improving their quality of life.

Area of Science:

  • Geriatrics
  • Neurology
  • Public Health

Background:

  • Epilepsy prevalence and incidence peak in later life, with approximately 25% of new cases in elderly individuals.
  • Many older adults with epilepsy have co-occurring neurodegenerative, cerebrovascular, or neoplastic diseases.
  • The unpredictable nature of seizures can lead to difficulties in diagnosis acceptance, loss of confidence, and independence in affected individuals.

Purpose of the Study:

  • To highlight the challenges and optimal management strategies for epilepsy in the elderly population.
  • To emphasize the impact of late-onset seizure disorders on healthcare systems and costs.
  • To advocate for coordinated healthcare programs to improve the quality of life for elderly patients with epilepsy.

Main Methods:

  • Review of epidemiological data on epilepsy in older adults.

Related Experiment Videos

  • Analysis of treatment outcomes with antiepileptic drugs.
  • Assessment of the impact of epilepsy on healthcare resources.

    • Main Results:

    • Complete seizure control is achievable in approximately 70% of elderly patients with antiepileptic drug treatment.
    • Seizures in older individuals can lead to physical injury and reduced morale.
    • The emergence of epilepsy in old age increases the burden on healthcare facilities and associated costs.

    Conclusions:

    • Optimal management necessitates prompt investigation, accurate diagnosis, effective treatment, and supportive patient education.
    • A coordinated approach among healthcare professionals is crucial for maintaining independence and enhancing the quality of life for this vulnerable group.
    • Addressing late-onset epilepsy is essential for managing healthcare burdens and improving patient outcomes.